HOME >> MEDICINE >> NEWS
Study says 43% of US adults at risk of heart disease are not utilizing aspirin therapy

WASHINGTON, DC, January 25, 2005 Preliminary survey results released today by the American College of Preventive Medicine (ACPM) found that 43% of U.S. adults aged 40 and older who are at increased risk of cardiovascular (CV) events and therefore potential candidates for doctor-recommended aspirin therapy based on current American Heart Association guidelines are not utilizing aspirin therapy to reduce their risk of heart attack or stroke. Increased risk can be defined as 10% risk or greater of heart attack or stroke over 10 years. The survey, which was conducted by Harris Interactive for the ACPM, was supported by an unrestricted educational grant from Bayer Aspirin.

When using the American Heart Association guidelines as a reference1, the survey found that aspirin is underutilized by both men and women aged 40 and over who are at increased risk for heart disease, and that this underutilization may be due to their tendency to underestimate their risk for a heart attack. The results were drawn from a nationally representative survey of 1,299 U.S. adult consumers (647 men, 652 women) age 40 and over and 533 healthcare professionals. The on-line survey was designed to assess barriers, beliefs and behaviors related to adoption of cardiovascular event prevention strategies, with a particular focus on aspirin use and adherence2.

"The survey findings have profound implications for all Americans aged 40 and over who are at risk for heart disease," commented George K. Anderson, MD, MPH, past president of the ACPM. "Despite significant educational efforts in recent years to elevate awareness among professionals and consumers about the proven benefits of aspirin therapy in reducing the risk of heart attack and recurrent stroke in individuals at increased risk, there is still less than adequate utilization. While health professionals report that they are discussing aspirin's benefits with appropriate patients, not nearly enough moderate-to-high risk peo
'"/>

Contact: Jennifer Bretsch
jkb@acpm.org
202-466-2044
American College of Preventive Medicine
25-Jan-2005


Page: 1 2 3 4 5

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Study says adults risk heart disease are not utilizing aspirin therapy

(Date:5/20/2013)... VHA Inc., the national health care ... population health improvement, announced a new offering to ... pursue population health management with a strategic ... the transition to value-based models of care. As ... of services, the offering integrates VHA expert advisory ...
(Date:5/20/2013)... have mapped the significance of heredity for common ... examined whether different forms of the disease share ... ischemic stroke, peripheral arterial disease and atherosclerosis of ... have suffered different types of cardiovascular disease. , ... atherosclerosis of the aorta followed by peripheral arterial ...
(Date:5/20/2013)... Gilman Law LLP, a leading pharmacy ... lawsuits, is troubled by a new study that reveals ... type 2 diabetes drugs are growing. The analysis, ... found that 71 Byetta pancreatic cancer reports had been ... as of June 30, 2012. Overall, Byetta ...
(Date:5/20/2013)... Newport News, VA (PRWEB) May 20, 2013 ... Jeffrey Carlson successfully performed a procedure using SpineFrontier’s FacetFuse ... Fusion Device System. The operation took place on ... Hospital in Newport News, VA. The surgery was ... a 66 year-old, female patient. , Dr. Carlson described ...
(Date:5/20/2013)... The study comprised over 24,000 Finnish subjects and ... revealed that a panel of 28 genetic markers ... coronary heart disease (CHD) (10-year risk ≥20%) over ... is an important preventive strategy for CHD, because ... high-risk group. "The results indicate that genetic markers ...
Breaking Medicine News(10 mins):Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 2Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 3Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 2Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 3
(Date:5/17/2013)... 17, 2013 Medical devices are any medical ... product. In light of their different mechanisms, actions and ... more complicated than drug trails due to their unique ... instead of evaluating both safety and efficacy (which is ... is the same as the SFDA) evaluate MDs for ...
(Date:5/17/2013)... DIEGO , May 17, 2013  Sorrento ... that its Fast-Track Advanced Technology Small Business Technology ... Institute of Allergy and Infectious Diseases (NIAID), a ... supporting the development of novel human antibody therapeutics ... aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... , May 17, 2013  Technology advances ... communicate internally. Faced with a constantly evolving communication ... and tactics for communicating with internal executives. It ... all the strategies, tactics and tools that are ... In a new study, Best Practices, LLC explores ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2
Cached News: